- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/39 - PancreasIslets of Langerhans
Patent holdings for IPC class A61K 35/39
Total number of patents in this class: 910
10-year publication summary
|
73
|
78
|
93
|
81
|
76
|
87
|
76
|
73
|
56
|
35
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1597 |
39 |
| ViaCyte, Inc. | 180 |
37 |
| Children's Medical Center Corporation | 1930 |
28 |
| Janssen Biotech, Inc. | 1714 |
22 |
| Sana Biotechnology, Inc. | 173 |
22 |
| President and Fellows of Harvard College | 6045 |
21 |
| The Regents of the University of California | 20574 |
20 |
| City of Hope | 1017 |
16 |
| Massachusetts Institute of Technology | 10208 |
15 |
| CRISPR Therapeutics AG | 364 |
15 |
| Cornell University | 3392 |
13 |
| Seraxis, Inc. | 20 |
12 |
| Regents of the University of Minnesota | 2770 |
11 |
| RegenLab USA LLC | 77 |
11 |
| Wake Forest University Health Sciences | 723 |
10 |
| Yeda Research and Development Co. Ltd. | 1365 |
10 |
| Kyoto University | 2892 |
9 |
| University of Louisville Research Foundation, Inc. | 729 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6600 |
8 |
| Accelerated Biosciences Corp. | 35 |
8 |
| Other owners | 574 |